Shefali Agarwal
CIK: 0001746830
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 12, 2026FATE
FATE THERAPEUTICS INC
Award(A)DirectStock Option (Right to Buy)
87.9K shares- - May 29, 2025FATE
FATE THERAPEUTICS INC
Award(A)DirectStock Option (Right to Buy)
55K shares- - Apr 4, 2025GRTS
Gritstone bio, Inc.
Other(J)DirectStock Option (Right to Buy)
51.8K shares- - Apr 4, 2025GRTS
Gritstone bio, Inc.
Other(J)DirectStock Option (Right to Buy)
937 shares- - Apr 4, 2025GRTS
Gritstone bio, Inc.
Other(J)DirectStock Option (Right to Buy)
19K shares- - Apr 4, 2025GRTS
Gritstone bio, Inc.
Other(J)DirectStock Option (Right to Buy)
38K shares- - Apr 4, 2025GRTS
Gritstone bio, Inc.
Other(J)DirectStock Option (Right to Buy)
51.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 |  FATE FATE THERAPEUTICS INC | Award(A) Stock Option (Right to Buy) | 87,900 | - | - | Direct |
| May 29, 2025 | FATE FATE THERAPEUTICS INC | Award(A) Stock Option (Right to Buy) | 55,000 | - | - | Direct |
| Apr 4, 2025 |  GRTS Gritstone bio, Inc. | Other(J) Stock Option (Right to Buy) | 51,800 | - | - | Direct |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | Other(J) Stock Option (Right to Buy) | 937 | - | - | Direct |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | Other(J) Stock Option (Right to Buy) | 19,000 | - | - | Direct |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | Other(J) Stock Option (Right to Buy) | 38,000 | - | - | Direct |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | Other(J) Stock Option (Right to Buy) | 51,800 | - | - | Direct |
1-7 of 7 transactions
About Agarwal Shefali
Agarwal Shefali (SEC CIK 0001746830) files insider reports with the SEC as Director of FATE THERAPEUTICS INC (FATE) and Director of Gritstone bio, Inc. (GRTS).
Signal8 holds 3 ownership filings by Agarwal Shefali, all Form 4s, filed between Apr 8, 2025 and Jun 15, 2026. Those filings report 7 transactions, from Apr 4, 2025 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Agarwal Shefali's filings is in SAN DIEGO, CA.
Recent filings by Agarwal Shefali
Other insiders filing for FATE THERAPEUTICS INC (FATE)
- TAHL CINDY
- Valamehr Bahram, President and CEO
- Redmile Group, LLC, Director
- Lee Michael Stewart, Director
- Xu Yuan, Director
- Jooss Karin, Director